- CA$75.53m
- CA$50.04m
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Strengthens Leadership Team With Appointment Of Andy Duncan As Senior Executive
Brief: Willow Biosciences Announces Completion Of Transformative Recapitalization Transactions To Form Atlas Energy Corp
Brief: Willow Biosciences Says Mark Hodgson To Be Appointed As President And CEO
Brief: Willow Announces Cancellation Of Previously Announced Non-Brokered Offering To Pursue Less Dilutive Alternatives
Brief: Willow Biosciences Announces Partnership With Global Ingredient Manufacturer To Develop High-Value Ingredient
Brief: Willow Announces Commercial License And Royalty Agreement With Kalsec
Brief: Willow Announces Commercial License And Royalty Agreement With Kalsec
Brief: Willow Biosciences Provides Corporate Update And Announces Signing Of A New Partnered Program
Brief: Willow Announces Brokered Private Placement Offering To Raise Up To $3 Mln
Brief: Willow Announces Product Development, Licensing Partnership With Laurus Labs
Brief: Willow Biosciences Announces Strategic Investment From Kalsec
Brief: Willow Plans For Significant Growth In 2024 On The Back Of A Successful 2023
Brief: Willow BiosciencesAdvancing Program To Develop Precise, Concise Manufacturing Routes To Advanced Intermediates, High-Value Active Pharma Ingredients
Brief: Willow And Leading Innovative Biopharmaceutical Company Advance Development Program To Manufacture Sustainable Intermediates And Active Pharmaceutical Ingredients
Brief: Willow Announces Filing Of Patent Application For Process To Produce Corticosteroids At Signficantly Reduced Cost
Brief: Willow Biosciences Announces Commercial Transition And Focus On Biooxi Platform
Brief: Willow Announces Collaboration With Biopharmaceutical Company To Develop Sustainable Intermediates And Active Pharmaceutical Ingredients